Early signs of mild dehydration include: Thirst and dry mouth Dark yellow or amber-colored urine healthy hydration typically produces pale yellow urine Decreased urination frequency or volume Fatigue and reduced energy levels often attributed to medication but may reflect dehydration Headaches particularly if new or worsening since starting therapy Dry skin and lips More concerning signs of moderate dehydration warrant prompt medical attention: Dizziness or lightheadedness , especially when standing (orthostatic symptoms) Rapid heartbeat or palpitations Confusion or difficulty concentrating Dry mucous membranes (mouth, eyes) Severe constipation unresponsive to usual measures Muscle cramps or weakness Patients with diabetes should be particularly vigilant, as dehydration can affect blood glucose readings and may contribute to hyperglycemic hyperosmolar state (HHS) in type 2 diabetes
On the other hand, there are clear reasons why someone might prefer the branded route
NHS access usually needs a BMI of 35 or above with a weight-related condition, through a specialist weight-management service, or the phased Mounjaro rollout for the highest-need group
Most of our patients are adults (typically ages 2565) who want a proactive approach to aging
Contact your GP, call NHS 111, or seek urgent care if you notice : Significant swelling, warmth, or redness spreading beyond the injection site Signs of infection, such as pus, increasing pain, or fever A hard, painful lump that does not resolve within a few weeks Severe or persistent abdominal pain, with or without vomiting seek urgent medical assessment, as this may require evaluation for serious conditions such as pancreatitis An allergic reaction, including rash, difficulty breathing, or swelling of the face or throat this requires immediate emergency care (call 999) Beyond local reactions, retatrutide like other agents in its class may cause systemic gastrointestinal side effects such as nausea, vomiting, and diarrhoea, particularly during dose escalation
Compounded GLP-1 medications historically referred to compounded semaglutide and tirzepatide